|
|
|
20 Mar 2006 |
Schering-Plough and PTC Therapeutics Announce Collaboration for Development of PTC's Preclinical Hepatitis C Compounds
|
|
20 Mar 2006 |
Q-Med submits DUROLANE regulatory file to the US FDA
|
|
17 Mar 2006 |
AnorMED Announces AMD070 Is Active In HIV Patients
|
|
16 Mar 2006 |
Metabasis Comments on Positive 48 Week HBV Data From Pradefovir Mesylate Phase 2 Study Reported by Valeant Pharmaceuticals
|
|
16 Mar 2006 |
Nastech Presents Successful In Vitro and In Vivo Results with Its RNAi Therapeutics Program for Influenza
|
|
15 Mar 2006 |
FDA Grants Cerexa Fast Track Designation for PPI-0903
|
|
14 Mar 2006 |
Human Genome Sciences Announces Positive Interim Results Of Phase 2b Clinical Trial Of Albuferon™ In Combination With Ribavirin In Treatment-Naïve Patients With Chronic Hepatitis C
|
|
14 Mar 2006 |
InSite Vision Announces Second of Two Phase 3 Clinical Trials Results Meet Primary and Secondary Efficacy End Points; Preparations for AzaSite(TM) New Drug Application
|
|
14 Mar 2006 |
Human Genome Sciences Reports Positive Interim Results Of Phase 2 Trial Of Albuferon™ In Combination With Ribavirin In Treatment-Experienced Patients With Chronic Hepatitis C
|
|
11 Mar 2006 |
Genmab Announces Update On AMG 714 Program With Amgen
|
|
10 Mar 2006 |
Mymetics announces NIH Plan to test HIV-AIDS vaccine candidate in non-human primate mode
|
|
10 Mar 2006 |
Samaritan Kicks Off Follow-On HIV Study
|
|
09 Mar 2006 |
Merck and Paratek Pharmaceuticals Sign Collaboration Agreement for Novel Antibiotic PTK 0796 Currently in Phase 1 Testing
|
|
09 Mar 2006 |
The New England Journal of Medicine Reports BARACLUDE(TM) (entecavir) Demonstrated Benefits Over Lamivudine In Treating Chronically Infected Hepatitis B Patients at 48 Weeks
|
|
09 Mar 2006 |
U.S. FDA Grants Traditional Approval for Gilead's Once-Daily HIV Medications Truvada(R) and Viread(R); 48-Week Data from Pivotal Study 934 Added to U.S. Prescribing Information for Both Products
|
|
08 Mar 2006 |
GeoVax announces IND “Safe to Proceed Status” granted by the FDA with planned Human Clinical Trials scheduled in April 2006 for its HIV/AIDS Vaccine
|
|
07 Mar 2006 |
Cubist Pharmaceuticals Reports Positive Outcome from FDA Anti-Infective Drugs Advisory Committee; PDUFA Date for FDA Review of CUBICIN sNDA is March 24th
|
|
06 Mar 2006 |
Tibotec Announces FDA Acceptance for Review of NDA for TMC114
|
|
06 Mar 2006 |
PharmAthene and Medarex Receive Orphan Drug Designation for Valortim(TM) to Treat Anthrax Infection
|
|
04 Mar 2006 |
Schering-Plough Provides Update on Phase II Study of Vicriviroc
|
|
04 Mar 2006 |
Anacor's Novel Topical Antifungal Agent for Onychomycosis Demonstrates Good Safety Profile and Diverse Activity in Multiple Preclinical Studies
|
|
03 Mar 2006 |
Wyeth Pharmaceuticals' Antibiotic Tygacil Receives Positive Opinion From European Regulatory Authority
|
|
02 Mar 2006 |
Sangamo BioSciences Licenses MaxCyte Cell Loading Technology for ZFP Therapeutic Program for HIV/Aids
|
|
02 Mar 2006 |
Enzo Receives Approval To Commence HIV Clinical Trial
|
|
01 Mar 2006 |
Northwest Biotherapeutics Presents New Data on Monoclonal Antibody to CXCR4
|
|
01 Mar 2006 |
ImQuest Pharmaceuticals, Inc. Licenses Entire Series Of Anti-HIV Therapeutic Compounds From Samjin Pharmaceutical Co.
|
|
28 Feb 2006 |
AVANT Announces that the European Regulatory Authorities Have Approved Rotarix(R) Rotavirus Vaccine
|
|
28 Feb 2006 |
ViroPharma Licenses Rights to Develop Novel Therapeutic for Treatment of Clostridium Difficile-Associated Disease
|
|
27 Feb 2006 |
Clinical Trial Results Show that Peregrine's First-In-Class Anti-Viral Agent Tarvacin(TM) is Safe and Well-Tolerated in HCV Patients
|
|
24 Feb 2006 |
FDA review date for Merck's investigational shingles vaccine extended to may 25, 2006
|
|
23 Feb 2006 |
Replidyne and Forest Laboratories Announce FDA Acceptance for Review of New Drug Application for Oral Antibiotic Faropenem Medoxomil
|
|
22 Feb 2006 |
Progenics Pharmaceuticals' HIV Drug, PRO 140, Receives FDA Fast-Track Designation
|
|
22 Feb 2006 |
Schering-Plough Reports NOXAFIL(R) (Posaconazole) NDA Granted FDA 6-Month Priority Review for Prevention of Invasive Fungal Infections
|
|
22 Feb 2006 |
Enrollment of Phase III study for Intercell’s Japanese Encephalitis Vaccine completed
|
|
22 Feb 2006 |
Pfizer Receives FDA Approval for EraxisTM to Treat Candidemia, a Potentially Life-Threatening Bloodstream Infection
|
|
21 Feb 2006 |
Ebola DNA Vaccine Produces Immune Responses in All Fully Vaccinated Volunteers in Phase 1 Trial
|
|
17 Feb 2006 |
CSL reveals encouraging results from Australian bird flu vaccine trial
|
|
17 Feb 2006 |
Biota Commences Phase 1 Clinical Trial of Common Cold Drug
|
|
17 Feb 2006 |
Elusys’ anthrax drug, Anthim™, superior to antibiotic as a post-exposure monotherapy
|
|
17 Feb 2006 |
New Data on Tibotec HIV/AIDS Investigational Product Portfolio
|
|
17 Feb 2006 |
FDA Approves Vusion(TM) Ointment for the Treatment of Diaper Dermatitis Complicated by Candidiasis
|
|
16 Feb 2006 |
American Pharmaceutical Partners Receives Two FDA Approvals for Ceftriaxone for Injection, USP, Maintaining Company's Leadership Position in the Cephalosporin Market
|
|
15 Feb 2006 |
Biolex Therapeutics Presents Results Highlighting Benefits of Locteron(TM) at 'Breakthroughs in Hepatitis' Session
|
|
15 Feb 2006 |
Peregrine Announces Completion of Planned Patient Enrollment and Dosing in Initial Tarvacin(TM) Anti-Viral Hepatitis C Phase 1 Trial
|
|
15 Feb 2006 |
AVANT Announces Start of Phase I/II Clinical Trial of Its Typhoid Fever Vaccine
|
|
15 Feb 2006 |
Acambis announces results from Phase 1 trial of C. difficile vaccine
|
|
15 Feb 2006 |
Robust Viral Load Reduction Successfully Achieved in Phase II Clinical Trial of ANA380 in Lamivudine-Resistant, Hepatitis B Patients
|
|
15 Feb 2006 |
Robust Viral Load Reduction Successfully Achieved in Phase II Clinical Trial of ANA380 in Lamivudine-Resistant, Hepatitis B Patients
|
|
15 Feb 2006 |
Panacos Reports Fourth Quarter and Full Year Results for 2005
|
|
15 Feb 2006 |
Nektar Announces That U.S. FDA Has Granted Orphan Drug Designation to the First Amphotericin B Inhalation Powder to Prevent Pulmonary Fungal Infections in Immunosuppressed Patients
|
| |
|
Results 1201 - 1250 of 1310 |
